United States · Bill · HR
H.R. 2892 (106th)
Access to Innovation for Medicare Patients Act of 1999
Introduced
21 September 1999
Last action
—
Status
Referred to the Subcommittee on Health and Environment.
Sponsors
—
Subjects
Discovery layer
Source updated
3 June 2026
Summary
Access to Innovation for Medicare Patients Act of 1999 - Amends title XVIII (Medicare) of the Social Security Act to provide for Medicare coverage of self-injected biologicals approved by the Food and Drug Administration that are prescribed for use in the treatment of the same disease or medical condition in lieu of a drug or biological which cannot be self-administered.
This text is taken from the official record. PoliticalRepo does not editorialize.
Timeline
No timeline events have been ingested for this record yet.
Votes
No vote records are attached yet.
Versions
No version snapshots stored. Document URLs remain at the source.
Documents
3 official files
Introduced in House (text)
Introduced in House (text)
Introduced in House · EN · 21 September 1999
Introduced in House (PDF)
Introduced in House · EN · 21 September 1999
Introduced in House
summary · EN · 21 September 1999
Sponsors
No sponsors or actors listed by the source.
Related records
No cross-record relationships stored yet.
Sources
PoliticalRepo is an index and interpretation layer, not the authoritative legal source.
- Official source: https://www.congress.gov/bill/106th-congress/house-bill/2892
- Open data entity: https://api.congress.gov/v3/bill/106/hr/2892